Fibrinogen is associated with EGFR mutation status and lymphatic metastasis in non-small cell lung cancer

In the previous decade, tyrosine kinase inhibitors (TKIs) have demonstrated significant effects in patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. However, sufficient tumor tissue for genetic testing cannot always be obtained in clinical setti...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jian, Xiao, Nan, Qiu, Chun, Li, Qin, Chen, Min, Zhang, Yao, Dai, Yong, Li, Lu, Zhang, Yue, Yang, Mi, Chen, Long, Liu, Lai Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312965/
https://www.ncbi.nlm.nih.gov/pubmed/30655825
http://dx.doi.org/10.3892/ol.2018.9652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312965/
https://www.ncbi.nlm.nih.gov/pubmed/30655825
http://dx.doi.org/10.3892/ol.2018.9652

Ejemplares similares